Telemus Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,375
Closed -$260K 352
2022
Q1
$260K Sell
11,375
-40
-0.4% -$978 0.02% 297
2021
Q4
$315K Sell
11,415
-130
-1% -$3.48K 0.03% 292
2021
Q3
$322K Sell
11,545
-1,400
-11% -$39.7K 0.03% 269
2021
Q2
$380K Sell
12,945
-750
-5% -$22.7K 0.03% 267
2021
Q1
$432K Sell
13,695
-1,294
-9% -$38K 0.03% 288
2020
Q4
$311K Sell
14,989
-1,561
-9% -$29.1K 0.02% 312
2020
Q3
$283K Buy
+16,550
New +$285K 0.02% 376
2017
Q1
Sell
-116,000
Closed -$1.68M 334
2016
Q4
$1.68M Buy
+116,000
New +$2.13M 0.23% 84

Other funds holding BHC

Telemus Capital's BHC Position: Q2 2022 in Review

Telemus Capital sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 11,375 shares — an estimated $260K sold.

Telemus Capital first reported a position in BHC in Q4 2016 and held it in 8 quarters. The position peaked at $1.68M in Q4 2016. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Telemus Capital reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Telemus Capital sold 11,375 Bausch Health shares in Q2 2022, an estimated $260K.
  • Telemus Capital first reported a position in Bausch Health in Q4 2016 and held it in 8 quarters.
  • Telemus Capital's Bausch Health position peaked at $1.68M in Q4 2016.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Telemus Capital's 13F filing for Q2 2022, filed 3 Aug 2022.